Epalza C, Valadés-Alcaraz A, González-Alba JM, Beltrán-Pavez C, Gutiérrez-López M, Rubio-Garrido M, Fortuny C, Frick MA, Muñoz Medina L, Moreno S, Sanz J, Rojo P, Navarro ML, Holguín Á, Pediatric obotCotSHA, Networks A: Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain. The Pediatric Infectious Disease Journal 2024, 43:40-48.
Tschumi N, Lukau B, Tlali K, Motaboli L, Kao M, Kopo M, Hänggi K, Mokebe M, Naegele K, Ayakaka I, Leuzinger K. Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho. Clinical Infectious Diseases. 2024 Apr 3:ciae185.
Zhang M, Ma Y, Wang Z, Wang G, Wang Q, Li X, Lin F, Zhang C. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017–2021. Virulence. 2024 Dec 31;15(1):2373105.
Brenner BG, Ibanescu RI, Oliveira M, Margaillan G, Lebouché B, Thomas R, Baril JG, Lorgeoux RP, Roger M, Routy JP, Montreal Primary HIV Infection (PHI) Cohort Study Group. Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022. Viruses. 2024 Jul 31;16(8):1230.